Ishita Drugs and Industries Ltd Q1 FY2023 profit at Rs. 16.62 lakhs

ISHITA DRUGS & INDUSTRIES LTD. has reported Standalone financial results for the period ended June 30, 2022.

Financial Results (Q1 FY2023) - QoQ Comparison

The company has reported total income of Rs. 3.39 crores during the period ended June 30, 2022 as compared to Rs. 3.9797 crores during the period ended March 31, 2022.

The company has posted net profit / (loss) of Rs. 0.1662 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs. 0.3748 crores for the period ended March 31, 2022.

The company has reported EPS of Rs. 0.56 for the period ended June 30, 2022 as compared to Rs. 1.25 for the period ended March 31, 2022.

Financials	Q1 FY2023	Q4 FY2022	% Change
Total Income	₹ 3.39 crs	₹3.9797 crs	-14.82%
Net Profit	₹0.1662 crs	₹0.3748 crs	-55.66%
EPS	₹0.56	₹1.25	-55.20%

Financial Results (Q1 FY2023) - YoY Comparison

The company has reported total income of Rs. 3.39 crores during the period ended June 30, 2022 as compared to Rs.2.9273 crores during the period ended June 30, 2021.

The company has posted net profit / (loss) of Rs.0.1662 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs.0.1361 crores for the period ended June 30, 2021.

The company has reported EPS of Rs.0.56 for the period ended June 30, 2022 as compared to Rs.0.46 for the period ended June 30, 2021.

Financials	Q1 FY2023	Q1 FY2022	% Change
Total Income	₹ 3.39 crs	₹2.9273 crs	15.81%
Net Profit	₹0.1662 crs	₹0.1361 crs	22.12%
EPS	₹0.56	₹0.46	21.74%

Shares of ISHITA DRUGS & INDUSTRIES LTD. was last trading in BSE at Rs. 46.05 as compared to the previous close of Rs. 49.00. The total number of shares traded during the day was 5285 in over 22 trades.

The stock hit an intraday high of Rs. 48.50 and intraday low of 45.00. The net turnover during the day was Rs. 238843.00.

Source : Equity Bulls

Keywords

IshitaDrugsandIndustries Q1FY23 ResultUpdate